Y-Mabs Therapeutics Inc

-1.59 (-4.69%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.41B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.87 Million
Adjusted EPS-$0.58
See more estimates
10-Day MA$32.74
50-Day MA$31.71
200-Day MA$36.83
See more pivots

Y-Mabs Therapeutics Inc Stock, NASDAQ:YMAB

230 Park Avenue, Suite 3350, New York, New York 10169
United States of America
Phone: +1.646.885.8505
Number of Employees: 125


Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.